CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in CollPlant Biotechnologies Ltd as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q3 2023
- Shares held
- 1.43M
- −97.3K (−6.4%) vs. Q3 2023
- Total value
- $9.14M
- +$591.5K (+6.9%) vs. Q3 2023
- New holders
- 2
- 2 more added
- Sold out
- 3
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pinnacle Associates Ltd | 468,109 | $2.99M | 0.05% | −10,200−2.1% | Reduced |
| Roumell Asset Management, LLC | 432,639 | $2.76M | 5.94% | −145,270−25.1% | Reduced |
| Villere St Denis J & Co LLC | 361,293 | $2.31M | 0.19% | +61,120+20.4% | Added |
| Brown Advisory Inc | 74,836 | $478.2K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 50,150 | $320.0K | 0.01% | +5,100+11.3% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,089 | $147.5K | 0.00% | −51−0.2% | Reduced |
| Bank of America Corp | 7,300 | $46.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 6,734 | $43.0K | 0.00% | +6,734 | New |
| The PNC Financial Services Group, Inc. | 3,600 | $23.0K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 1,539 | $9.00K | 0.01% | 00.0% | Unchanged |
| GWM Advisors LLC | 500 | $3.19K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 371 | $2.37K | 0.00% | +371 | New |
| Focused Wealth Management, Inc | 242 | $1.55K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 250 | $1.50K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 71 | $454 | 0.00% | −8,485−99.2% | Reduced |
| Qube Research & Technologies Ltd | 6 | $38 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1 | $12 | 0.00% | −120−99.2% | Reduced |
| UBS Group AG | 0 | $0 | 0.00% | −5,690−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |